We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$118B
AUM Growth
+$8.59B
Cap. Flow
-$401M
Cap. Flow %
-0.34%
Top 10 Hldgs %
16.92%
Holding
8,702
New
1,333
Increased
3,126
Reduced
2,721
Closed
1,293

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$346M
2
AVGO icon
Broadcom
AVGO
+$326M
3
BA icon
Boeing
BA
+$263M
4
COF icon
Capital One
COF
+$258M
5
OXY icon
Occidental Petroleum
OXY
+$257M

Sector Composition

Rank Sector Weight
1 Technology 7.15%
2 Financials 5.56%
3 Consumer Discretionary 5.28%
4 Industrials 4.73%
5 Healthcare 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLGT icon
6776
Radiant Logistics
RLGT
$392M
$90K ﹤0.01%
16,772
-37,774
-69% -$218K
ADAP
6777
DELISTED
Adaptimmune Therapeutics
ADAP
$89K ﹤0.01%
+19,759
New +$103K
CRK icon
6778
Comstock Resources
CRK
$4.23B
$88K ﹤0.01%
+12,378
New +$98.6K
MFIN icon
6779
CALL
Medallion Financial
MFIN
$247M
$88K ﹤0.01%
+37,000
New +$84.3K
VHI icon
6780
Valhi
VHI
$477M
$88K ﹤0.01%
2,460
+687
+39% +$27.3K
VIVS
6781
PUT
VivoSim Labs
VIVS
$1.28M
$88K ﹤0.01%
139
-40
-22% -$26.9K
ONDK
6782
PUT
DELISTED
On Deck Capital, Inc.
ONDK
$88K ﹤0.01%
18,900
+2,500
+15% +$10.6K
OREX
6783
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
$87K ﹤0.01%
30,000
+12,000
+67% +$36K
AHT
6784
CALL
Ashford Hospitality Trust
AHT
$20.4M
$86K ﹤0.01%
14
-9
-39% -$56.3K
SB icon
6785
Safe Bulkers
SB
$765M
$86K ﹤0.01%
37,354
-69,207
-65% -$153K
UAN icon
6786
PUT
CVR Partners
UAN
$1.24B
$86K ﹤0.01%
2,460
-500
-17% -$21.8K
CORV
6787
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$86K ﹤0.01%
19,107
+4,971
+35% +$18K
AVEO
6788
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$86K ﹤0.01%
3,872
+2,774
+253% +$21.8K
SNAK
6789
DELISTED
Inventure Foods, Inc.
SNAK
$86K ﹤0.01%
20,047
+2,848
+17% +$11.7K
AGEN
6790
CALL
Agenus
AGEN
$282M
$85K ﹤0.01%
1,111
+97
+10% +$6.82K
NL icon
6791
NLI Holdings
NL
$305M
$85K ﹤0.01%
+12,006
New +$94.4K
PCYO icon
6792
Pure Cycle
PCYO
$270M
$85K ﹤0.01%
+10,909
New +$78.7K
NPTN
6793
CALL
DELISTED
NEOPHOTONICS CORP
NPTN
$85K ﹤0.01%
11,000
-700
-6% -$5.92K
ACTG icon
6794
Acacia Research
ACTG
$468M
$84K ﹤0.01%
20,384
+8,269
+68% +$38.5K
GERN icon
6795
PUT
Geron
GERN
$949M
$84K ﹤0.01%
30,200
-3,400
-10% -$9.03K
HMY icon
6796
CALL
Harmony Gold Mining
HMY
$12.4B
$84K ﹤0.01%
50,700
-10,900
-18% -$23.4K
LYG icon
6797
Lloyds Banking Group
LYG
$89.2B
$84K ﹤0.01%
23,858
-124,190
-84% -$441K
SRGA
6798
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$84K ﹤0.01%
+481
New +$68.4K
AMRN
6799
PUT
Amarin Corp
AMRN
$300M
$83K ﹤0.01%
+1,035
New +$64.3K
NNA
6800
DELISTED
Navios Maritime Acquisition Corporation
NNA
$83K ﹤0.01%
+3,776
New +$90K

Similar funds

Citadel Advisors's Q2 2017 Portfolio in Review

As of Q2 2017, Citadel Advisors held 8,702 positions worth $118B, up 7.8% from $109B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors's Q2 2017 filing shows 1,333 new, 3,126 increased, 2,721 reduced and 1,293 closed positions. Its largest new stake was Equity Residential: 2,436,064 shares worth $160M. The largest sale was Walt Disney, an estimated $550M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Citadel Advisors's largest Q2 2017 buy was Equity Residential: 2,436,064 shares worth $160M.
  • Citadel Advisors added most to Applied Materials in Q2 2017, an estimated $346M increase.
  • Citadel Advisors's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $549M.
  • Citadel Advisors fully exited Walt Disney in Q2 2017, selling an estimated $550M.
  • Citadel Advisors's ten largest holdings make up 17% of its $118B portfolio in Q2 2017.
  • Citadel Advisors opened 1,333 new positions and closed 1,293 in Q2 2017.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $118B.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.